(3-METHOXYPROPYL)TRIPHENYLPHOSPHONIUM BROMIDE, 95%, 250mg

5-Methyl-1,2,3,4-tetrahydroquinoxaline, 5g

2-Bromo-6-nitrophenol, 97.0%, 25g

tert-Butyl 4-hydroxybutylmethylcarbamate, 95.0%, 25g

5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfonyl)-1H-benzo[d]imidazole, 95.0%, 1g

N-(6-Oxo-6,9-dihydro-1H-purin-2-yl)acetamide, 97.0%, 100g

2-((TERT-BUTOXYCARBONYL)AMINO)-2-(4,4-DIFLUOROCYCLOHEXYL)ACETIC ACID, 95.0%, 100mg

tert-Butyl 2-oxo-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate, 98%, 1g

4-(3,5-Dimethylphenoxy)benzoic acid, 97.0%, 5g

9-(4-Biphenylyl)carbazole>98.0%(GC)1g

Dialysis systems Spectra/Por® Float-A-Lyzer® G2 Filling volume 5 ml, 500–1000 dalton(s), 12 Piece(s)

4-Bromo-2-fluorobenzoyl Chloride>98.0%(GC)(T)5g

Cinnamyl Cinnamate>80.0%(GC)25g